STAT Plus: The founder of Adimab believes he can combat Covid-19 — and whatever pandemic comes next
One of biotech’s most respected entrepreneurs is betting the novel coronavirus won’t be the last deadly outbreak in his lifetime — and that vaccines won’t be enough to stop a future pandemic from bringing the world to a halt once more.
Tillman Gerngross, the Dartmouth bioengineering professor behind the biotech company Adimab, has founded a new firm dedicated to making antibodies that could protect against the novel coronavirus, called SARS-CoV-2, in addition to any future coronaviruses that might make the leap from animals to humans.
Continue to STAT Plus to read the full story…
